top of page

Sophie Smith is the CEO and Founder of Nabta Health, a hybrid healthcare platform for women enabling the accelerated detection, diagnosis, and treatment of chronic diseases in women in emerging markets. Prior to this she read History at the University of Cambridge, then completed an MBA with Quantic School of Business and Technology and after working as a technology consultant she launched a number of impact start-ups. Sophie is empowering women all of the globe to effectively manage their health.At The Legacy Globe, we are collectively working alongside each other to leave lasting legacies which will empower future generations. How do you feel that your upbringing has shaped you? Growing up as the oldest of eight children in Croydon- one of the most diverse and multicultural parts of the UK, I have always had a deep appreciation for different perspectives and the importance of inclusion. As the daughter of two doctors, one of whom ran the first major digitisation programs for NHS England, I was acutely aware of the benefits that patient-centric technology solutions could bring to healthcare, and this fuelled my passion for using technology to solve real-world problems.Nabta Health is a hybrid healthcare platform for women providing personalised healthcare to women in emerging markets. Tell us more about the platform and the motivation behind you founding it. Nabta Health is a patient-centric healthcare platform designed to address the specific needs of women in emerging markets. We provide personalised and affordable care for chronic and complex diseases, empowering women to take control of their health. Women were largely excluded from clinical trials until 1993, and still today account for only 19% of clinical trial participants, the majority of whom hail from white, Caucasian populations. This means that women - and in particular, women of Middle Eastern, African or South Asian origin - suffer significantly worse health outcomes than their male counterparts. For example, it takes four times longer on average to diagnose women with the same chronic conditions as men, even though women are twice as likely to see a doctor in the first place. Our vision is to eliminate these systemic gender and also racial biases by building a woman-centric model of care, by and for women in underserved markets.Prior to founding Nabta, you worked as a technology consultant for Accenture and have also launched a number of impact startups. In early 2022 you founded the 2022 Female Angels movement. What inspired you to initiate this movement? On several occasions, while working as a technology consultant and then as an entrepreneur, the gender gap in investment funding and the lack of support for women-led startups was made extremely apparent. This came to a head in late 2021 when I was in the middle of raising our Seed round, and could find only 2 publicly listed female angel investors in the Middle East. The 2022 Female Angels movement (, founded in early 2022, was the result, and today is working to bridge this gap by empowering women to become angel investors and support women-led businesses.How did you handle setbacks in your businesses and what kept you going?Setbacks are inevitable in any entrepreneurial journey. I've learned that resilience, adaptability, and a strong support system are key to overcoming challenges. My passion for making a positive impact keeps me motivated to push through difficult times, and my four children and very active family life keep me honest.What does the word legacy mean to you and what legacy do you want to leave behind? Legacy to me is about creating a lasting impact that extends well beyond myself and my immediate circle of family and friends. I aspire to leave behind a legacy of empowered women in emerging markets by building affordable, accessible, and woman-centric healthcare options, and I look forward to a world in which gender equity is a reality, and the systemic biases that plague our healthcare ecosystem today are at least on their way to being eliminated.

Final Background
bottom of page